• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟比洛芬 PLGA-PEG 纳米球:羟丙基-β-环糊精对离体人皮肤渗透和体内局部抗炎功效的作用。

Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.

机构信息

Department of Physical Chemistry, Institute of Nanoscience and Nanotechnology, Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain.

出版信息

Colloids Surf B Biointerfaces. 2013 Oct 1;110:339-46. doi: 10.1016/j.colsurfb.2013.04.045. Epub 2013 May 4.

DOI:10.1016/j.colsurfb.2013.04.045
PMID:23743255
Abstract

In this study, flurbiprofen (FB) loaded poly(d,l-lactide-co-glycolide) (PLGA) and PLGA with poly(ethylene glycol) (PLGA-PEG) nanospheres (NSs) with and without hydroxypropyl-β-cyclodextrin (HPβCD) were developed as skin controlled delivery systems. X-ray diffraction was used to determine the physical state of the entrapped drug. Results showed that the drug in PLGA NSs was present in the form of a molecular dispersion (dissolved state) in the polymers, whereas in PLGA-PEG NSs, the drug was present in both molecular dispersion and crystalline forms. Furthermore, HPβCD provided solubilization of the free FB present on the surface of the PLGA-PEG NSs and a complete amorphosization of the drug was obtained. Optical analyses using TurbiscanLab(®) demonstrated that HPβCD provided an efficient steric stability of the NSs, preventing particle aggregation. The ex vivo permeation profiles of the NSs and conventional FB solution were evaluated using human skin. Results demonstrated that only PLGA-PEG NSs showed slight permeation improvement. However, after 24h, the FB retained in the skin was about 9-fold higher with NSs compared with the control solution, attributed to the reservoir effect of NSs acting as a depot, sustaining the drug and limiting its systemic absorption. In vivo performance of NSs was evaluated by assessing anti-inflammatory efficacy in TPA-induced mouse ear edema. Topically applied NSs significantly decreased in vivo inflammation compared to the control solution and the anti-inflammatory efficacy of HPβCD NSs was stronger than NSs without HPβCD. In vivo skin irritation evaluated by the in vivo Draize test showed no irritation of the formulations tested.

摘要

在这项研究中,研制了负载氟比洛芬(FB)的聚(D,L-丙交酯-共-乙交酯)(PLGA)和聚(乙二醇)(PLGA-PEG)纳米球(NS)以及含有和不含有羟丙基-β-环糊精(HPβCD)的 NS,作为皮肤控制释放系统。X 射线衍射用于确定包封药物的物理状态。结果表明,PLGA NS 中药物以分子分散(溶解状态)的形式存在于聚合物中,而在 PLGA-PEG NS 中,药物既以分子分散形式存在,又以结晶形式存在。此外,HPβCD 提供了表面游离 FB 的增溶作用,并且药物完全非晶化。使用 TurbiscanLab(®)进行的光学分析表明,HPβCD 为 NS 提供了有效的空间稳定性,防止了颗粒聚集。使用人体皮肤评估 NS 和常规 FB 溶液的体外渗透曲线。结果表明,只有 PLGA-PEG NS 显示出轻微的渗透改善。然而,24 小时后,与对照溶液相比,NS 保留在皮肤中的 FB 约增加了 9 倍,这归因于 NS 作为储库的缓释作用,持续释放药物并限制其全身吸收。通过评估 TPA 诱导的小鼠耳肿胀中的抗炎功效来评估 NS 的体内性能。与对照溶液相比,局部应用 NS 显著降低了体内炎症,并且含有 HPβCD 的 NS 的抗炎功效强于不含 HPβCD 的 NS。通过体内 Draize 试验评估的体内皮肤刺激性表明,所测试的制剂没有刺激性。

相似文献

1
Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.氟比洛芬 PLGA-PEG 纳米球:羟丙基-β-环糊精对离体人皮肤渗透和体内局部抗炎功效的作用。
Colloids Surf B Biointerfaces. 2013 Oct 1;110:339-46. doi: 10.1016/j.colsurfb.2013.04.045. Epub 2013 May 4.
2
Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.羟丙基-β-环糊精对冷冻干燥和γ辐照的 PLGA 和 PLGA-PEG 两亲嵌段共聚物纳米球在眼部氟比洛芬给药中的作用。
Int J Nanomedicine. 2012;7:1357-71. doi: 10.2147/IJN.S28481. Epub 2012 Mar 9.
3
Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent.卡洛芬从纳米颗粒的离体渗透:通过人、猪和牛皮肤作为抗炎剂的综合研究。
Int J Pharm. 2016 Mar 30;501(1-2):10-7. doi: 10.1016/j.ijpharm.2016.01.056. Epub 2016 Jan 27.
4
Optimization, Biopharmaceutical Profile and Therapeutic Efficacy of Pioglitazone-loaded PLGA-PEG Nanospheres as a Novel Strategy for Ocular Inflammatory Disorders.载吡格列酮的 PLGA-PEG 纳米球的优化、生物制药特性和治疗效果:一种治疗眼部炎症性疾病的新策略。
Pharm Res. 2018 Jan 3;35(1):11. doi: 10.1007/s11095-017-2319-8.
5
Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.具有改善雾化特性的载胰岛素聚乳酸-羟基乙酸共聚物/环糊精大孔颗粒:经大鼠肺部给药后的体内沉积及降血糖活性
J Control Release. 2009 Apr 2;135(1):25-34. doi: 10.1016/j.jconrel.2008.12.011. Epub 2008 Dec 25.
6
PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.用于氟比洛芬眼部给药的聚乳酸-羟基乙酸共聚物纳米球:药物释放与相互作用
J Pharm Sci. 2008 Dec;97(12):5306-17. doi: 10.1002/jps.21383.
7
PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization.通过实验设计优化的聚乙二醇化聚乳酸-羟基乙酸共聚物纳米球用于右布洛芬的眼部给药——体外、离体和体内表征
Colloids Surf B Biointerfaces. 2016 Sep 1;145:241-250. doi: 10.1016/j.colsurfb.2016.04.054. Epub 2016 May 3.
8
Injectable in situ forming depot systems: PEG-DAE as novel solvent for improved PLGA storage stability.可注射原位形成储库系统:聚乙二醇二丙烯酸酯作为改善聚乳酸-羟基乙酸共聚物储存稳定性的新型溶剂
Int J Pharm. 2009 Apr 17;371(1-2):33-9. doi: 10.1016/j.ijpharm.2008.12.019. Epub 2008 Dec 24.
9
Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.载姜黄素的 PLGA-PEG-PLGA 三嵌段共聚物胶束的制备、药代动力学和体内分布。
J Colloid Interface Sci. 2011 Feb 1;354(1):116-23. doi: 10.1016/j.jcis.2010.10.024. Epub 2010 Oct 16.
10
Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.地洛瑞林的肺部给药:大孔聚乳酸-羟基乙酸共聚物微粒和羟丙基-β-环糊精复合物
Pharm Res. 2004 Jul;21(7):1119-26. doi: 10.1023/b:pham.0000032997.96823.88.

引用本文的文献

1
Nasal In-Situ Gels of Brij-Enriched Novasomes as Optimistic Nanovesicular Carriers for Enhancing Anti-Depressant Action of Agomelatine.富含月桂醇聚醚的新型脂质体鼻腔原位凝胶作为增强阿戈美拉汀抗抑郁作用的理想纳米囊泡载体
AAPS PharmSciTech. 2025 Apr 17;26(5):110. doi: 10.1208/s12249-025-03097-5.
2
Luteolin loaded PEGylated cerosomes: a novel treatment for MRSA skin infections.载有木犀草素的聚乙二醇化纳米脂质体:一种治疗耐甲氧西林金黄色葡萄球菌皮肤感染的新方法。
BMC Microbiol. 2025 Mar 31;25(1):182. doi: 10.1186/s12866-025-03873-0.
3
Potential role of NSAIDs loaded nano-formulations to treat inflammatory diseases.
负载非甾体抗炎药的纳米制剂在治疗炎症性疾病中的潜在作用。
Inflammopharmacology. 2025 Mar;33(3):1189-1207. doi: 10.1007/s10787-025-01644-x. Epub 2025 Feb 14.
4
Navigating Skin Delivery Horizon: An Innovative Approach in Pioneering Surface Modification of Ultradeformable Vesicles.探索皮肤递药新领域:超弹性囊泡表面改性的开创性创新方法。
AAPS PharmSciTech. 2024 Jun 4;25(5):126. doi: 10.1208/s12249-024-02847-1.
5
Optimization of Ursolic Acid Extraction in Oil from Annurca Apple to Obtain Oleolytes with Potential Cosmeceutical Application.优化从安努卡苹果油中提取熊果酸以获得具有潜在药妆应用的油质体
Antioxidants (Basel). 2023 Jan 18;12(2):224. doi: 10.3390/antiox12020224.
6
A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration.关于通过不同给药途径增强硝酸戊四唑纳米系统抗真菌活性的最新综述。
Drug Deliv. 2023 Dec;30(1):2179129. doi: 10.1080/10717544.2023.2179129.
7
Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, study, and exploratory clinical appraisal.硝酸戊环脒载入经皮纳米载体用于有效治疗体癣:设计特征、研究和探索性临床评估。
Drug Deliv. 2022 Dec;29(1):1100-1111. doi: 10.1080/10717544.2022.2057619.
8
Thymol-loaded PLGA nanoparticles: an efficient approach for acne treatment.载百里香酚 PLGA 纳米粒:治疗痤疮的有效方法。
J Nanobiotechnology. 2021 Nov 8;19(1):359. doi: 10.1186/s12951-021-01092-z.
9
Surface-Modified Multifunctional Thymol-Loaded Biodegradable Nanoparticles for Topical Acne Treatment.用于局部痤疮治疗的表面改性多功能载百里酚可生物降解纳米颗粒
Pharmaceutics. 2021 Sep 18;13(9):1501. doi: 10.3390/pharmaceutics13091501.
10
Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations.右旋布洛芬的治疗进展:前药与纳米技术制剂
Pharmaceutics. 2021 Mar 19;13(3):414. doi: 10.3390/pharmaceutics13030414.